State-owned pharmaceutical company PT Indofarma has responded to its subsidiary PT Indofarma Global Mendika which was declared in default or bankrupt by the court, assuring stability of operations in the parent company and other subsidiaries.
Hilda Yani, Corporate Secretary of Indofarma, said that this decision was the result of a creditor vote on the peace proposal submitted by Indofarma Global Medika. This decision is part of the legal process that has been carried out in compliance with regulations in Indonesia.
She said that as part of the company’s commitment, Indofarma is trying to maintain stability and sustainability both in the parent company…
